Quality of Life Outcomes Following Aortofemoral and Iliofemoral Bypass Surgery in Patients With Peripheral Arterial Disease: A Two-Year Follow-Up Study
Saeed Alqahtani, Fahad Aljaber, Bander Alharbi, Riyadh Masoud

TL;DR
This study shows that bypass surgeries for peripheral arterial disease improve patients' quality of life over two years, with factors like age and smoking affecting outcomes.
Contribution
The study provides new insights into long-term quality of life improvements and predictors following aortofemoral and iliofemoral bypass surgeries.
Findings
Significant improvements in physical and mental quality of life were observed two years post-surgery.
Older age, unemployment, lower income, high BMI, smoking, and comorbidities were linked to lower quality of life scores.
Patients with comorbidities showed significant postoperative improvements despite lower initial scores.
Abstract
Introduction: Peripheral arterial disease is a circulatory disorder characterized by reduced blood flow to the extremities, predominantly affecting the lower limbs. This study aims to evaluate the impact of aortofemoral and iliofemoral bypass surgeries on patients' quality of life two years post operation and identify predictors of quality-of-life improvements. Methods: This cross-sectional study included adult patients with aortoiliac disease who underwent bypass surgery (aortofemoral or iliofemoral) at East Jeddah General Hospital from January 2020 to December 2022. Quality of life was assessed using the Arabic version of the Short Form Health Survey 12 (SF-12) preoperatively and two years postoperatively. Data on sociodemographic factors (age, sex, education, income) and medical factors (smoking, BMI, comorbidities) were collected. Statistical analyses included descriptive…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
| Characteristic | n (%) | |
| Gender | Male | 164 (59.64) |
| Female | 111 (40.36) | |
| Age (years) | 66.51 ± 6.88 | |
| Educational level | Less than high school | 59 (21.46) |
| High school | 114 (41.46) | |
| Diploma | 11 (4.00) | |
| Bachelor's | 83 (30.18) | |
| Master's | 7 (2.55) | |
| PhD | 1 (0.36) | |
| Income | 0-4000 SAR | 109 (39.64) |
| 4001-8000 SAR | 90 (32.73) | |
| More than 8000 SAR | 76 (27.64) | |
| Occupational status | Unemployed/retired | 209 (76) |
| Employed | 66 (24) | |
| Co-morbidities | Diabetes | 170 (61.18) |
| Ischemic heart disease | 152 (55.27) | |
| Dyslipidemia | 198 (72) | |
| Hypertension | 239 (86.91) | |
| Chronic kidney disease | 46 (16.73) | |
| Live disease | 13 (4.73) | |
| Characteristics | Preoperative SF-12 scores | Postoperative SF-12 scores | Difference between preoperative and postoperative (p-value) | ||||||||||
| Physical | P-value | Mental | P-value | Physical | P-value | Mental | P-value | Physical component | Mental component | ||||
| Gender | Male | 54.5 ± 10.67 | 0.824 | 52.08 ± 9.67 | 0.979 | 61.24 ± 9.07 | 0.901 | 61.50 ± 7.15 | 0.036 | <0.001 | <0.001 | ||
| Female | 53.34 ± 8.50 | 51.98 ± 6.75 | 63.41 ± 7.65 | 58.50 ± 6.00 | |||||||||
| Educational level | Less than high school | 54.00 ± 10.0 | 0.754 | 52.80 ± 9.80 | 0.356 | 60.48 ± 7.0 | 0.562 | 58.44 ± 12.74 | 0.468 | 0.004 | 0.002 | ||
| High school | 56.25 ± 9.80 | 51.65 ± 9.00 | 65.06 ± 11.80 | 58.13 ± 11.70 | |||||||||
| Diploma | 59.50 ± 11.50 | 57.20 ± 11.20 | 81.12 ± 10.50 | 74.76 ± 14.76 | |||||||||
| Bachelor's | 50.00 ± 7.70 | 52.20 ± 6.20 | 57.60 ± 9.70 | 64.86 ± 8.06 | |||||||||
| Master's | 60.70 ± 9.00 | 58.50 ± 9.00 | 69.60 ± 10.00 | 76.05 ± 11.70 | |||||||||
| PhD | 54.00 | 52.50 | 60.48 ± 7.0 | 68.00 | |||||||||
| Income | 0-4000 SAR | 55.34 ± 9.00 | 0.943 | 54.88 ± 10.00 | 0.612 | 62.87 ± 10.90 | 0.643 | 57.97 ± 10.35 | 0.137 | 0.046 | 0.029 | ||
| 4001-8000 SAR | 51.25 ± 11.50 | 49.75 ± 10.50 | 57.37 ± 13.20 | 52.44 ± 10.65 | |||||||||
| More than 8000 SAR | 53.70 ± 8.30 | 51.70 ± 8.30 | 61.07 ± 10.30 | 60.95 ± 10.78 | |||||||||
| Occupational status | Unemployed/retired | 51.34 ± 9.00 | 0.003 | 49.88 ± 10.00 | <0.001 | 56.47 ± 10.80 | 0.006 | 57.37 ± 13.23 | <0.001 | <0.001 | <0.001 | ||
| Employed | 60.70 ± 11.50 | 58.20 ± 11.50 | 67.35 ± 13.50 | 65.86 ± 15.00 | |||||||||
| Co-morbidities | Diabetes | 49.64 ± 9.13 | <0.001 | 48.99 ± 8.12 | 0.007 | 56.83 ± 8.72 | <0.001 | 57.83 ± 7.15 | <0.001 | <0.001 | <0.001 | ||
| Ischemic heart disease | 46.19 ± 8.12 | <0.001 | 46.5 ± 10.21 | <0.001 | 47.43 ± 9.12 | <0.001 | 54.43 ± 7.66 | <0.001 | <0.001 | <0.001 | |||
| Dyslipidemia | 49.04 ± 11.23 | <0.001 | 49.47 ± 7.77 | 0.018 | 57.39 ± 7.15 | <0.001 | 57.39 ± 6.22 | <0.001 | <0.001 | <0.001 | |||
| Hypertension | 51.7 ± 10.21 | 0.003 | 50.0 ± 9.85 | 0.046 | 60 ± 10.23 | 0.591 | 60.7 ± 8.9 | 0.591 | <0.001 | <0.001 | |||
| Chronic kidney disease | 47.51 ± 8.53 | <0.001 | 50.21 ± 7.81 | 0.07 | 53.72 ± 11.51 | <0.001 | 55.72 ± 10.01 | <0.001 | <0.001 | <0.001 | |||
| Live disease | 47.67 ± 7.77 | <0.001 | 48.22 ± 4.78 | <0.001 | 53.52 ± 7.13 | <0.001 | 54.52 ± 6.2 | <0.001 | <0.001 | <0.001 | |||
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPeripheral Artery Disease Management · Aortic aneurysm repair treatments · Cardiac, Anesthesia and Surgical Outcomes
Introduction
Peripheral arterial disease is a circulatory disorder characterized by reduced blood flow to the extremities, predominantly affecting the lower limbs. It is estimated that approximately 200 million adults worldwide are affected by peripheral arterial disease, with its incidence rising notably in individuals over the age of 70 years [1,2]. The disease typically presents with lower limb pain on exertion and at rest in severe cases. Atherosclerotic plaques, which narrow arterial flow lumens, are the primary pathological mechanism underlying peripheral arterial disease [3,4].
Numerous risk factors contribute to the development and progression of peripheral arterial disease, including race, ethnicity, uncontrolled diabetes, smoking, obesity, hypertension, dyslipidemia, increased age, family history of peripheral arterial disease, and elevated levels of homocysteine [5,6]. For instance, individuals with a history of heavy smoking or poorly controlled diabetes exhibit a significantly heightened risk of peripheral arterial disease, often associated with increased disease severity and elevated risks of limb amputation [7,8].
Lifestyle modifications, encompassing physical exercise and dietary adjustments, play pivotal roles in both preventing and managing peripheral arterial disease [7]. However, implementing these modifications can be challenging, particularly as peripheral arterial disease limits patients' exercise tolerance, exacerbating the underlying pathological mechanisms. Pharmacological interventions, such as cilostazol and supervised exercise programs, have shown promise in improving functional performance and mitigating symptoms [9].
When peripheral arterial disease progresses beyond the point where medications and lifestyle modifications provide substantial benefit, surgical interventions become necessary [10]. Despite advancements in endovascular techniques, surgical procedures remain fundamental in peripheral arterial disease management, addressing challenges such as occlusive disease patterns, patient fitness for anesthesia, extent of tissue loss, and anatomical considerations. Endovascular surgery, compared to open approaches, has demonstrated favorable outcomes in terms of complication rates, hospitalization duration, and long-term mortality [11].
Among the most commonly employed surgical interventions for peripheral arterial disease are bypass procedures, which offer versatility in treating arterial occlusions ranging from the aorta to the foot. Bypass surgeries have shown favorable long-term patency rates and improvements in quality-of-life measures, as evidenced by studies utilizing the Short Form-36 (SF-36) questionnaire [12]. However, there is a paucity of research assessing the long-term impact of bypass surgery on patients' quality of life two years post operation. Therefore, our current study aims to elucidate the impact of aortofemoral and iliofemoral bypass surgeries on patients' quality of life two years post operation. Additionally, we seek to identify sociodemographic and medical predictors associated with quality-of-life improvements in these patient populations.
Materials and methods
Study design
This study employed a cross-sectional design to assess the impact of lower limb revascularization surgery on patients' quality of life. Data were collected at two time points: preoperatively and two years postoperatively.
Study participants
The study included adult patients diagnosed with aortoiliac disease who underwent bypass surgery (aortofemoral or iliofemoral) at East Jeddah General Hospital between January 2020 and December 2022. Inclusion criteria were patients aged 18 years and older with documented aortoiliac disease requiring surgical intervention. Exclusion criteria included patients with non-aortoiliac peripheral arterial disease, those unable to complete the Short Form Health Survey 12 (SF-12) questionnaire, and patients who underwent non-bypass revascularization procedures.
Surgical procedures
Aortofemoral and iliofemoral bypass surgeries were performed by a team of experienced vascular surgeons. The choice of graft (synthetic or autologous vein) and specific surgical technique (end-to-end anastomosis, end-to-side anastomosis) was based on individual patient anatomy and disease severity. Intraoperative management adhered to standard protocols, including anticoagulation, anesthesia, and postoperative care.
Data collection
Patients' quality of life was assessed using the validated Arabic version of the SF-12. The SF-12 comprises physical and mental components and consists of 12 Likert scale-based questions [13]. Patients completed the SF-12 questionnaire during preoperative consultations and at a follow-up visit two years postoperatively. Additional data collected preoperatively included patients' symptoms, ankle-brachial pressure index (ABPI), and a comprehensive sociodemographic and medical history (age, sex, education, income, smoking status, BMI, and comorbidities). Data were entered into a secure database and anonymized to ensure patient confidentiality. Data accuracy was verified through double-entry and periodic audits.
Statistical analysis
Descriptive statistical analysis was performed using IBM SPSS software version 25.0 (IBM Corp., Armonk, NY). Counts, proportions, averages, and standard deviations were calculated to summarize baseline characteristics and SF-12 scores. The normality of patients' SF-12 scores was assessed using the Shapiro-Wilk test. Correlation analysis included independent t-tests and one-way ANOVA to explore correlations between various sociodemographic and medical characteristics and SF-12 scores. Regression analysis encompassed linear regression to investigate the correlation between smoking pack-years and SF-12 scores, and multiple linear regression to identify independent predictors of improvements in the physical and mental components of SF-12. Statistical significance was set at P < 0.05.
Results
Sociodemographic characteristics
The study included 275 patients. Of the patients, 59.64% were males and 40.36% were females, with an average age and standard deviation of 66.51 and 6.88, respectively. About 63% of patients had no university education, while the remaining had a university and higher education. Of the patients, 39.64% earned less than 4000 Saudi riyals (SAR), 32.73% earned between 4000 and 8000 SAR, and 27.64% earned more than 8000 SAR per month, and the majority of our patients were unemployed or retired (Table 1).
Factors associated with quality of life
Linear regression analysis revealed a significant association between older age and lower preoperative and postoperative SF-12 scores (P = 0.025, 0.016, and <0.001, respectively). Employment correlated with increased postoperative physical and mental SF-12 scores (P < 0.001). In postoperative analysis, gender showed statistically significant differences in mental scores, with males scoring higher (P = 0.036). Lower income was associated with lower postoperative mental scores (P = 0.046). All sociodemographic characteristics exhibited significant improvements in both preoperative and postoperative physical and mental scores (Table 2).
Table 2: Preoperative and postoperative SF-12 scores by patient characteristics.Physical and mental component scores are presented as mean ± standard deviation. P-values are considered significant if <0.05.SF-12: Short Form Health Survey 12; SAR: Saudi riyal.
Significant differences were observed in preoperative SF-12 physical and mental scores based on BMI categories, with lower scores in non-normal weight patients compared to normal weight patients (P < 0.05). Lower postoperative physical and mental scores were observed in all BMI categories compared to normal weight, except for obese patients regarding postoperative mental scores. A significant correlation was observed between smoking pack-years and SF-12 change (P < 0.001, r^2^ = -0.48).
Patients with any medical comorbidity had significantly lower physical SF-12 scores compared to those without (P < 0.05). Statistically significant lower mental SF-12 scores were observed in patients with any comorbidity except for hypertension. Patients with comorbidities had lower postoperative physical and mental scores (P < 0.05). However, all mentioned comorbidities showed significant improvements in SF-12 physical and mental scores postoperatively (P < 0.001).
Discussion
Our study aimed to assess the effectiveness of lower limb revascularization surgery on the physical and mental quality of life of patients after a two-year follow-up period. The initial observation revealed significantly low SF-12 scores in patients with peripheral arterial disease. However, all patients, regardless of sociodemographic and medical characteristics, demonstrated improvements in both their physical and mental SF-12 components postoperatively.
Male sex was identified as a predictor of better improvement in the mental component of SF-12 compared to females. This finding aligns with existing literature indicating that females often score lower on health measures compared to males [14,15]. Furthermore, unemployed or retired individuals exhibited significantly lower physical and mental scores and experienced lesser improvements in both scales, consistent with previous studies demonstrating lower long-term physical and psychological well-being in unemployed populations.
Patients' comorbidities had a substantial impact on their preoperative and postoperative physical and mental scores, with the exception of hypertension, likely due to its high prevalence among peripheral arterial disease patients. Previous research has highlighted the independent influence of comorbidities such as ischemic heart disease, liver disease, and chronic kidney disease on patients' quality of life [16]. BMI categories and smoking pack-years were significantly associated with lower physical and mental quality of life, consistent with previous studies [17]. These correlations may be attributed to their contribution to the etiopathogenesis and progression of peripheral arterial disease.
Implications of our research include the importance of targeting potential risk factors for lower improvement in the physical and mental quality of life to optimize postoperative outcomes. This includes implementing smoking cessation programs, providing weight loss advice and dietary interventions, and promoting physical activity.
The study has several limitations, including a relatively small sample size, absence of controls for disease severity, and lack of information regarding participants' psychiatric history. To overcome these limitations, future research endeavors should aim for larger-scale investigations that incorporate robust controls for confounding factors, including disease severity, and consider comprehensive assessments of participants' psychiatric history to provide a more nuanced understanding of the study outcomes.
Conclusions
Our study aimed to identify predictors of lower quality of life following lower limb revascularization surgery in patients with peripheral arterial disease. Factors such as male sex, unemployment or retirement, and various medical comorbidities including diabetes, ischemic heart disease, dyslipidemia, chronic kidney disease, and liver disease, along with obesity and high smoking pack-years, emerged as significant predictors. These findings emphasize the importance of targeting these risk factors to optimize postoperative outcomes and enhance the physical and mental quality of life for patients undergoing revascularization surgery. Through targeted interventions, such as smoking cessation programs, weight management strategies, and comprehensive medical management, healthcare providers can strive to improve the overall well-being of patients with peripheral arterial disease undergoing surgical intervention.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1The global burden of peripheral artery disease J Vasc Surg Eid MA Mehta K Barnes JA 111911267720233656577910.1016/j.jvs.2022.12.015 · doi ↗ · pubmed ↗
- 2Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis Lancet Glob Health Song P Rudan D Zhu Y Fowkes FJI Rahimi K Fowkes FGR Rudan I 102010307201910.1016/S 2214-109X(19)30255-431303293 · doi ↗ · pubmed ↗
- 3Update on the pathophysiology and medical treatment of peripheral artery disease Nat Rev Cardiol Golledge J 4564741920223499720010.1038/s 41569-021-00663-9 · doi ↗ · pubmed ↗
- 4Pathophysiology of peripheral arterial disease (PAD): a review on oxidative disorders Int J Mol Sci Signorelli SS Marino E Scuto S Di Raimondo D 43932120203257569210.3390/ijms 21124393 PMC 7352779 · doi ↗ · pubmed ↗
- 5Peripheral arterial disease, prevalence and cumulative risk factor profile analysis Eur J Prev Cardiol Eraso LH Fukaya E Mohler ER 3rd Xie D Sha D Berger JS 7047112120142273968710.1177/2047487312452968 PMC 4436703 · doi ↗ · pubmed ↗
- 6Burden of peripheral artery disease and its attributable risk factors in 204 countries and territories from 1990 to 2019 Front Cardiovasc Med Lin J Chen Y Jiang N Li Z Xu S 868370920223549803410.3389/fcvm.2022.868370 PMC 9039520 · doi ↗ · pubmed ↗
- 7Impact of risk factor control on peripheral artery disease outcomes and health disparities Vasc Med Pohlman FW Ford CB Weissler EH 3233322720223538751610.1177/1358863 X 221084360 PMC 10908093 · doi ↗ · pubmed ↗
- 8Peripheral arterial disease: pathophysiology, risk factors, diagnosis, treatment, and prevention J Vasc Nurs Muir RL 26302720091948685210.1016/j.jvn.2009.03.001 · doi ↗ · pubmed ↗
